Among three patients with PoPH, one of CTP class B-C died of progressive liver failure despite treatment for PoPH with tadalafil (a phosphodiesterase 5 [PDE5] blocker). The gene discussed is PDE5A; the disease is Pulmonary arterial hypertension associated with portal hypertension.